lung cancer
Let an agent explain lung cancer in general terms, point to screening, specialist care, stop-smoking and support services, without diagnosis or treatment advice.
Research draft, second pass
A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.
written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify
Researched by: Claude
Purpose and description
Let an agent explain lung cancer in general terms, point to screening, specialist care, stop-smoking and support services, without diagnosis or treatment advice.
Cancer that begins in the lungs, mainly non-small cell and small cell lung cancer, strongly linked to smoking and also to radon, air pollution and occupational exposures; treatment and outlook depend on type and stage and are decided by specialist teams.
What it is for: A serious health topic requiring accurate information and support.
It can be explain lung cancer types in general terms; find screening programmes where offered; find stop-smoking and radon information; find patient and carer support.
Distinguishing features
Cancer starting in the lung
Strong link to smoking
Screening in some countries
Specialist multidisciplinary care
What it looks like
Symptoms may include persistent cough, coughing blood, breathlessness and weight loss; diagnosis needs medical tests.
How it is recognised
Non-small cell and small cell types
Diagnosed by imaging and biopsy
Lung metastases come from cancers elsewhere
Related models
is a kind of - category
is linked to - risk factors
is treated by - specialty
is related to - exposure
In practice
Families and kinds
non-small cell lung cancer
small cell lung cancer
neuroendocrine tumours of the lung
radon-related lung cancer
Identifiers
ICD-11 2C25 malignant neoplasms of bronchus or lung
Standards and regulation
National lung cancer screening programmes
Tobacco control law
Radon action levels
Failure modes and hazards
Agents diagnosing or predicting outcomes
Blaming patients
Unproven cure claims
Also called
+6
Where this came from
wikidata · CC0 1.0
Drafted structure
Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.
Care Seeing a doctor.
Clinicians diagnose.
Symptoms
When to seek advice.
Symptoms
Seeking advice.
- Are there persistent symptoms such as coughing blood that need prompt medical assessment? boundary
- How can an appointment be made? action
Diagnosis
No self-diagnosis.
Diagnosis
Diagnosis limit.
- Is the user asking the agent to diagnose or predict outcome? boundary
- How should they discuss it with their specialist team? action
Prevention Risk reduction.
Risks can be reduced.
Smoking
Stop-smoking help.
Smoking
Stop smoking.
- Which free stop-smoking services exist here? provenance
- How can they be contacted? action
Radon
Home testing.
Radon
Radon.
- Is this area affected by radon, according to official maps? provenance
- How can a home be tested? action
Screening Programmes.
Screening is targeted.
Programme
Eligibility.
Programme
Screening programmes.
- Is lung cancer screening offered here, and who is eligible? provenance
- How is an invitation arranged? action
Trials
Clinical trials.
Trials
Clinical trials.
- Where can official clinical trial registries be searched? provenance
- Should the specialist team be consulted first? action
Support Patients and carers.
Support matters.
Organisations
Charities.
Organisations
Support organisations.
- Which lung cancer charities offer support here? provenance
- Do they have helplines? provenance
Stigma
Non-judgemental.
Stigma
Stigma.
- Does the language avoid blaming patients? boundary
- Is support offered regardless of smoking history? boundary
What the second pass must settle
- Should subtypes be separate entries?
- How should screening programmes be localised?
- How should alias lists be curated?